Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[T]he fraternal interaction among fans from dozens of countries and the local public reminded us that isolationism is not the dominant sentiment among 349 million Americans.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Instead of discussing problems, or even finding solutions, those who led the G6 are [now] showering U.S. President Donald Trump with compliments and presenting him with gifts.